Monthly Archives: August 2016

American Survival Magazine Launches Blog on Steemit

August 30, 2016 – – August 30, 2016; Boynton Beach, FL: Survivalist magazine, a respected and reputable member of the emergency preparedness industry, proudly announces the launching of their new blog on Steemit.com. The company recently announced implementing measures to reduce its carbon footprint and become more digital friendly. In conjunction with their new website, the new blog hosted on Steemit.com, appears to help solidify their stance of becoming more environmentally aware.

“We are embracing the future of the emerging sharing economy where attention is the most valuable commodity!” states George Shepherd, CEO and founder of Survivalist magazine. “The world is changing and our society as a whole cannot evolve without a liquid exchange of a value for value economy where the best ideas, thoughts, and resources are shared,” he explains.

Steemit.com is a new social media platform that combines the sharing of content with the advantages of a cryptocurrency ecommerce exchange system. Members of the site are encouraged to create new content and share it on a scheduled basis. The content that is shared can then be read by others and “upvoted,” to show support and assist the author with earning Steem, Steem Dollars, and Steem Power, which in turn determines the value of the content.

“What is value? It’s something that only the free market can decide. The blockchain technology of the Steemit platform, we believe may be the evolution of money and commerce,” Shepherd explains one of the key factors that separates Steemit from traditional social media platforms.

The emergency preparedness community is constantly expanding as people begin to develop fears and insecurities related to more frequent natural disasters, terrorism, and national security. In the age of technological advancement, many of them will begin the journey towards becoming better prepared through emergency preparedness resources they can find easily online. With the company’s recent transition and increased reliance on digital services as a preventative measure against the escalating cost of commodities, Survivalist magazine appears prepared to retain its position atop the industry ladder.

Survivalist magazine, one of the most respected leaders in the emergency preparedness and disaster survival industry, strives to maintain daily contact with their fans, followers, and members through a variety of online portals, such as webinars, podcasts, summits, workshops, articles, white papers, emails, DIY projects, survival guides and new blog posts on Steemit.

###

Contact Survivalist Magazine:

George Shepherd
714-436-1234
support@survivalist.com
217 N. Seacrest Blvd, Ste #9
Boynton Beach, FL 33425

ReleaseID: 60012077

Global Constipation Pipeline Landscape and Therapeutics Development Market H2 2016

RnRMarketResearch adds Constipation Pipeline Market Research to its database.

Pune, India – August 30, 2016 /MarketersMedia/ —

Constipation Pipeline Market Companies Involved in Therapeutics Development are AlbireoPharma, Ardelyx, Inc., Astellas Pharma Inc., Braintree Laboratories, Inc., ,CJ HealthCare Corp. EA Pharma Co Ltd, Ironwood Pharmaceuticals, Inc., Kissei Pharmaceutical Co., Ltd., Motus Therapeutics Inc, NGM Biopharmaceuticals, Inc., RaQualia Pharma Inc., ,Sanwa Kagaku Kenkyusho Co., Ltd. Shire Plc, SK Biopharmaceuticals Co., Ltd., Sucampo Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., Synergy Pharmaceuticals, Inc., Synthetic Biologics, Inc., Torrent Pharmaceuticals Limited and Yuhan Corporation.

The report provides comprehensive information on the therapeutics under development for Constipation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Constipation and features dormant and discontinued projects.

Get discount on this research report at http://www.rnrmarketresearch.com/contacts/discount?rname=674879

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Constipation
• The report reviews pipeline therapeutics for Constipation by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Constipation therapeutics and enlists all their major and minor projects
• The report assesses Constipation therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Constipation

Purchase a copy of this research report which includes 121 pages with TOC at http://www.rnrmarketresearch.com/contacts/purchase?rname=674879

Reasons to buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Constipation
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Constipation pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Email: sales@rnrmarketresearch.com
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/global-constipation-pipeline-landscape-and-therapeutics-development-market-h2-2016/130214

Release ID: 130214

Lupaka Gold Reports Financial Highlights for the Period Ended June 30, 2016

VANCOUVER, BC / ACCESSWIRE / August 30, 2016 / Lupaka Gold Corp. (TSXV: LPK) (FSE: LQP) (“Lupaka Gold” or “the Company”) reports its financial results for the six months ended June 30, 2016.

The following is taken from the Company’s condensed consolidated interim Financial Statements and Management’s Discussion and Analysis for the six months ended June 30, 2016, both of which are filed at www.sedar.com under the Company’s profile.

Notable events – the Company’s events of note for the six months ended June 30, 2016 and to date are as follows:

On August 25, 2016, the Company announced the appointment of Lucio Pareja to its Board. Lucio brings to the Board his extensive experience in the development and ongoing operations of producing underground and open pit mines in Peru. The Company also announced that the Board had accepted the resignation of director Jaime Pinto;

On June 30, 2016, the Company announced that it had:

executed a definitive Pre-Paid Forward Gold Purchase Agreement with PLI Huaura Holdings LP (“PLI Financing”), a limited partnership organized under the laws of British Columbia, to fund the completion of development and initiate production at the Invicta Gold Project, upon the Company’s completion of certain conditions precedent;

completed a bridge loan financing for gross proceeds of $750,000 with a group of third-party individuals (83%) and Insiders of the Company (17%). The Company paid $8,100 cash in finders’ fees and $16,300 in other costs in connection with third-party investors; and

On February 22, 2016 the Company announced that it had completed a non-brokered private placement of common shares for total gross proceeds of $419,500 (see “Outstanding Share Data” below for additional details) and completed its second run-of-mine bulk test of 532 tonnes, achieving total recoveries of 87.52% for Gold, 91.18% for Silver and 91.52% for Copper;

Summarized Financial Highlights – all amounts are in Canadian Dollars unless otherwise stated:

Six months ended June 30

2016
($000’s)
2015
($000’s)
Operating expenses

Exploration
704
1,804
General and administration
280
603

Operating loss
984
2,407
Finance income – interest

(5)
Foreign exchange (gain) loss
(17)
8

Loss for the period
967
2,410

Loss per share – Basic and diluted
$0.01
$0.03

Exploration and development expenses – all such expenses relate to the Peru operations of the Company and totalled $704,000 for 2016 compared to $1,804,000 for 2015, a net decrease of $1,100,000 for the period, as a result of: a net decrease of $920,000 in Camp, Community Relations and Related costs; a net decrease of $178,000 in Project Administration; and a net decrease of $2,000 in Other Expenses.

General and administration expenses – all such expenses relate to the Canadian operations of Lupaka Gold and totalled $272,000 for 2016 compared to $603,000 for 2015, with the decrease of $331,000 being the result of: A net decrease of $167,000 in Salaries and Benefits; a decrease of $147,000 in Shareholder and Investor Relations; a decrease of $16,000 in Office and General expenses; an increase of $12,000 in Professional and Regulatory Fees; and a net decrease of $13,000 in Travel and Other expenses.

A snapshot of the Company’s balance sheet is as follows:

In thousands of dollars
June 30,
2016
     December 31,
2015
Cash and cash equivalents
293
52
Working capital (defined as current assets less current liabilities)
(1,395)
(1,816)
Total assets
28,938
29,450
Total liabilities
2,423
2,215
Shareholders’ equity
26,515
27,235

The principal changes in the Company’s cash during the six months ended June 30, 2016 were as follows:

Cash used in operating activities in the six months ended June 30, 2016 was $1,082,000 ($2,161,000 – six months ended June 30, 2015), principally to fund the Company’s loss for the period of $967,000 ($2,410,000 – six months ended June 30, 2015), non-cash charges including depreciation of $29,000 ($58,000 – six months ended June 30, 2015), and share-based compensation of $53,000 ($57,000 – six months ended June 30, 2015), and offset by a $17,000 gain on disposal of equipment ($Nil – six months ended June 30, 2015), as well as a net decrease of $180,000 in non-cash working capital (net increase of $134,000 – six months ended June 30, 2015).

There was $17,000 in investing activities in the six months ended June 30, 2015, including $20,000 in proceeds on sale of equipment and $3,000 in purchases of equipment, compared with net cash from investing activities of $34,000 in the three months ended March 31, 2015 for purchases of equipment.

Net cash from financing activities in the six months ended June 30, 2016 totalled $1,275,000, consisting of $400,000 in proceeds from a February 2016 private placement, $750,000 in proceeds from a bridge loan that closed on June 30, 2016 and $150,000 from exercises of Placement Warrants.

Total current liabilities as at June 30, 2016 totalled $1,764,000 ($1,937,000 – December 31, 2015), comprised of accounts payable and accrued liabilities, mostly for community and Invicta project-related obligations, as well as an accrued liability of $644,000 for severance due to the Company’s former President & CEO. Long-term liabilities consisted of provisions for reclamation of $269,000 ($278,000 – December 31, 2015), the difference being attributable to changes in foreign exchange rates from December 31, 2015 to June 30, 2016 and the recorded balance of a bridge loan of $401,000 ($Nil – December 31, 2015) that closed on June 30, 2016.

Status of PLI Financing

Subsequent to the June 30, 2016 PLI Financing announcement, the Company and PLI have been working to complete the various closing conditions of the Agreement.

Gordon Ellis, President and CEO of Lupaka Gold commented, “Both the due diligence and the fulfilling of the PLI Financing Conditions Precedent have been long and comprehensive processes. One positive outcome is that Lupaka now has detailed corporate documentation and contractor documents that it will be able to build on for many years to come. We anticipate that we will be able to complete the balance of what is necessary soon, thereby enabling us to begin the on-site development work required to commence mining and processing mineralized material.”

Neither the TSX Venture Exchange nor its Regulation Service Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this news release.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lupaka Gold Corp., Investor Relations at +1 (604) 681-5900, e-mail: info@lupakagold.com or visit the Company’s website at www.lupakagold.com.

Cautionary Note Regarding the Invicta Production Decision

The decision to commence production at the Invicta Gold Project and the Company’s plans for a mining operation as referenced herein (the “Production Decision and Plans”) were based on economic models prepared by the Company in conjunction with management’s knowledge of the property and the existing preliminary estimate of measured, indicated and inferred mineral resources on the property. The Production Decision and Plans were not based on a preliminary economic assessment, a pre-feasibility study or a feasibility study of mineral reserves demonstrating economic and technical viability. Accordingly, there is increased uncertainty and economic and technical risks of failure associated with the Production Decision and Plans, in particular the risk that mineral grades will be lower than expected, the risk that construction or ongoing mining operations are more difficult or more expensive than expected, the risk that the Company will not be able to transport or sell the mineralized rock it produces to local custom toll mills on the terms it expects, or at all; production and economic variables may vary considerably, due to the absence of a detailed economic and technical analysis according to and in accordance with NI 43-101.

Cautionary Statements Regarding Forward Looking Information

All statements, trend analysis and other information contained in this press release relative to anticipated future events or results constitute forward-looking statements. All statements, other than statements of historical fact, included herein, including, without limitation, any statements relating to the Pre-Paid Forward Gold Purchase Agreement (the “Agreement”) with PLI Huaura Holdings LP (“PLI”), the receipt of and anticipated use of proceeds of the PLI financing, the Company’s plans and intentions for Invicta, the expected benefits from a Company owned processing facility and mineral resource estimates, are forward-looking statements. Forward-looking statements are based on assumptions, estimates and opinions of management at the date the statements are made that the Company believes are reasonable, including: that the Agreement is consummated on the anticipated terms, that the supplies, equipment, personnel, permits, and local community approvals required to conduct the Company’s planned pre-production and development activities will be available on reasonable terms, that the Company will be able to comply with the delivery and other obligations in the Agreement, that the contemplated Company owned processing facility will, if acquired or constructed, achieve the expected benefits, that results of exploration activities will be consistent with management’s expectations and that the Company will not experience any material accident, labour dispute, or failure of equipment and with respect to the planned mining operations at Invicta; that pre-production mine development can be completed in the time and for the cost projected; that the Company will be able to obtain funding for planned production expenses; that mineralization on the Invicta project will be of the grades and in the locations expected; that the Company will be able to extract and transport mineralized rock efficiently and sell the mineralized rock at the prices and in the manner and quantities expected; that permits will be received on the terms and timeline expected and that other regulatory or permitting issues will not arise; that mining methods can be employed in the manner and at the costs expected and that such methods yield the results the Company expects them to. However, forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks, uncertainties and other factors include, among others: all of the risks described in this news release; failure of the PLI financing to complete on the proposed terms or at all, including due to the Company’s inability to complete the conditions precedent, the risk that the contemplated Company owned processing facility will not be completed or will not achieve the expected benefits, the risk that actual results of exploration and development activities will be different than anticipated; that the Company will not be able to comply with the delivery or other obligations in the Agreement and the risk that PLI will enforce its security over the Company’s assets, including its mineral properties; that cost of labour, equipment or materials will increase more than expected; that the future price of gold will decline; that the Canadian dollar will strengthen against the U.S. dollar; that mineral resources are not as estimated; unexpected variations in mineral resources, grade or recovery rates; risks related to shipping mineralized rock; the risk that local mills cannot or will not buy or process mineralized rock from the planned production for the prices expected or at all; risk of accidents, labour disputes and other risks generally associated with mineral exploration; unanticipated delays in obtaining or failure to obtain community, governmental or regulatory approvals or financing; and all of the risks generally associated with the development of mining facilities and the operation of a producing mine, as well as the risks described in the Company’s annual information form, which is available on SEDAR at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results to not be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned not to place undue reliance on forward-looking information due to the inherent uncertainty thereof. Lupaka Gold does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements.

SOURCE: Lupaka Gold Corp.

ReleaseID: 444552

China Minerals Announces Hearing Dates Set for Legal Action Against Province of BC

VANCOUVER, BC / ACCESSWIRE / August 30, 2016 / China Minerals Mining Corporation (TSXV: CMV) (OTC Pink: HWTHF) (“China Minerals” or the “Company”) announces that a three day hearing is scheduled to be heard on November 28, 29 and 30, 2016, at the courthouse at 800 Smithe Street, Vancouver, British Columbia, with respect to China Minerals’ legal action against the government of British Columbia.

The Company’s Executive Chairman Ling Zhu stated: “We remain deeply troubled by the manner in which our company has been treated by government and are pleased that the hearing dates have been set.” Mr. Zhu added: “We have learned that the government of British Columbia has changed its approach to engaging mineral tenure holders in other incremental treaty agreements entered into after our litigation was filed, and we look forward to having the Supreme Court of British Columbia review what occurred in China Minerals’ case.”

For further information on the legal action see China Minerals’ news releases dated January 25, 2016, March 9, 2016 and May 25, 2016, copies of which are available under China Minerals’ SEDAR profile at www.sedar.com. A copy of the judicial review petition and supporting affidavit are filed on China Minerals’ website available at: www.chinamineralsmining.com.

The Company supports reconciliation between the province and aboriginal groups – provided existing third party rights are protected or properly compensated.

About China Minerals Mining Corporation

China Minerals Mining Corporation is a Canadian based exploration and development company with offices located in Vancouver, B.C. and Beijing, China. China Minerals’ goal is to build an international mining company.

For more information on China Minerals, please contact the Company at 1-888-629-1505 or the Company at (604) 629-1505, or visit the Company’s website at www.chinamineralsmining.com.

ON BEHALF OF THE BOARD OF DIRECTORS

“signed by Ling Zhu”

Ling Zhu
Executive Chairman

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of accuracy of this release.

Cautionary Statement Regarding “Forward-Looking” Information

Some of the statements contained in this news release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as “plans”, “expects”, “intends”, “is expected”, “potential”, “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond China Minerals’ control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. China Minerals undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.

SOURCE: China Minerals Mining Corporation

ReleaseID: 444546

Airesurf Announces Amalgamation Agreement

TORONTO, ON / ACCESSWIRE / August 30, 2016 / Airesurf Networks Holdings Inc. (“Airesurf” or the “Corporation”) announces that Airesurf, IsoEnergy Ltd. (“IsoEnergy”) and 2532314 Ontario Ltd. (“IsoEnergy Subco”), a wholly-owned subsidiary of IsoEnergy, have entered into an amalgamation agreement (the “Amalgamation Agreement”) dated August 30, 2016, pursuant to which IsoEnergy will acquire all of the issued and outstanding common shares in the capital of Airesurf (the “Airesurf Common Shares”) by way of a “three-cornered” amalgamation involving Airesurf, IsoEnergy and IsoEnergy Subco (the “Proposed Transaction”).

Pursuant to the terms of the Proposed Transaction, IsoEnergy Subco and Airesurf will amalgamate (the “Amalgamation”) under the provisions of the Business Corporations Act (Ontario) to form a new corporation, which will become a wholly-owned subsidiary of IsoEnergy; each issued and outstanding Airesurf Common Share will be cancelled; and each Airesurf shareholder (other than a dissenting shareholder) will receive in exchange for such Airesurf shareholder’s Airesurf Common Shares so cancelled, 0.020833 common shares in the capital of IsoEnergy (the “IsoEnergy Common Shares”) for each Airesurf Common Share held immediately prior to the effective time of the Amalgamation. Completion of the Proposed Transaction is subject to the satisfaction or waiver of certain conditions, as set out in the Amalgamation Agreement, including the approval by the Airesurf shareholders of the Amalgamation as discussed below. A copy of the Amalgamation Agreement has been filed under Airesurf’s profile on www.sedar.com.

Upon completion of the Proposed Transaction, approximately 0.8% of the issued and outstanding IsoEnergy Common Shares will be held by former Airesurf Shareholders.

Airesurf Shareholders’ Meeting

In order to be effective, the Amalgamation requires approval by a majority of not less than two-thirds of the votes cast by Airesurf shareholders present in person or by proxy at a meeting of Airesurf shareholders. Airesurf has called a meeting (the “Airesurf Meeting”) of its shareholders to be held on September 29, 2016 at 10:00 a.m. for purposes of passing a resolution approving the Amalgamation. Airesurf has fixed the close of business on August 29, 2016 as the record date for the purposes of determining Airesurf shareholders entitled to receive notice of the Airesurf Meeting and to vote at the Airesurf Meeting.

About IsoEnergy

IsoEnergy is a mineral exploration company that was incorporated under the laws of the Province of British Columbia on February 2, 2016. The principal business activity of IsoEnergy is the acquisition and exploration of early stage mineral properties. Currently, IsoEnergy is focused on the exploration of its two principal uranium exploration properties, the “Radio Project” and the “Thorburn Lake Project”, in each case, located in the Athabasca Basin of Saskatchewan.

FOR MORE INFORMATION, PLEASE CONTACT:

Lisa McCormack, President
Airesurf Networks Holdings Inc.
T: (416) 361-2515

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

Caution Regarding Forward Looking Statements:

Certain information included in this press release constitute “forward-looking statements”. Such forward-looking statements include, without limitation, statements regarding the Amalgamation, the business of IsoEnergy and the completion of the Proposed Transaction. Where the Corporation expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to the risk that the conditions precedent to the Proposed Transaction will not be fulfilled, including obtaining the requisite shareholder approval. Accordingly, undue reliance should not be placed on forward- looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Corporation does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Airesurf Networks Holdings Inc.

ReleaseID: 444545

Crane Company Offers Special Promotion on Rentals

SEATTLE, WA / ACCESSWIRE / August 30, 2016 / Coast Crane Company, with a location in Seattle, WA, has announced that they are offering a service customer discount. People are encouraged to bring their crane into any of the 11 Coast Crane service centers in order to receive a 10% discount on a crane rental while the service is being performed. The company has a large rental ready fleet available on their website.

Greg Bellcoff from Coast Crane Company says: “We understand that when a crane has to be repaired or serviced, it can lead to significant downtime. By renting a crane from our extensive fleet, this downtime can be avoided. With the 10% discount we offer, costs are minimized.”

Coast Crane Company was founded in 1970. Today, it is one of the country’s largest crane sales and crane rental companies. With one of the greatest selections of cranes and locations on the West Coast and in Alaska, Hawaii, and Canada, the company provides the most comprehensive lifting equipment for the construction industry.

The company focuses primarily on regular service. “At Coast Crane Company our number one priority is ensuring that you have fully operational equipment to use,” adds Greg Bellcoff. “We encourage our clients to commit to regular crane servicing and inspection to keep their fleet in the best shape possible. Regular maintenance of your crane makes it easier to repair small problems before they become larger issues. Having your equipment inspected routinely can actually lower the cost of repairs overall, as you will not have to worry about sudden breakdowns and emergency repairs.” People are encouraged to learn more about crane service options through the company’s website.

The company is able to provide a range of services for all makes and models, thereby keeping fleets up and running. These include preventive maintenance, major hydraulic and electrical systems repair, crane remounts, replacements or repairs of LMI, crane inspection and certification, boom, chassis, and structural components, and engine replacement for tier upgrades. More details are available to those who visit the company Facebook page, where relevant industry news is also shared.

Contact Coast Crane Company:

Greg Bellcoff
800-400-2726
gregb@coastcrane.com
8250 5th Avenue S
Seattle, WA 98108

SOURCE: Coast Crane Company

ReleaseID: 444542

Global Warts Pipeline Landscape and Therapeutics Development Market H2 2016

RnRMarketResearch adds Warts Pipeline Market Research to its database.

Pune, India – August 30, 2016 /MarketersMedia/ —

Warts Pipeline Market Companies Involved in Therapeutics Development are 3M Drug Delivery Systems, Aclaris Therapeutics, Inc., Agilvax, Inc., Aviragen Therapeutics, Inc., Biogenomics Limited, BioMAS Ltd., Cytovation AS, Foamix Pharmaceuticals Ltd., G&E Herbal Biotechnology Co., Ltd., Laboratories Ojer Pharma S.L., LEO Pharma A/S, Nielsen Biosciences, Inc., Novan, Inc., Novartis AG, Promius Pharma, LLC, RXi Pharmaceuticals Corporation, Tamir Biotechnology, Inc. and Verrica Pharmaceuticals Inc.

The report provides comprehensive information on the therapeutics under development for Warts, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Warts and features dormant and discontinued projects.

Get discount on this research report at http://www.rnrmarketresearch.com/contacts/discount?rname=674874

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Warts
• The report reviews pipeline therapeutics for Warts by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Warts therapeutics and enlists all their major and minor projects
• The report assesses Warts therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Warts

Purchase a copy of this report which includes 85 pages with TOC at http://www.rnrmarketresearch.com/contacts/purchase?rname=674874

Reasons to buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Warts
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Warts pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For more information, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Email: sales@rnrmarketresearch.com
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/global-warts-pipeline-landscape-and-therapeutics-development-market-h2-2016/130211

Release ID: 130211

Elements Restaurant in Princeton Wins NJ Monthly’s 2016 Top 25 Restaurants In NJ

Elements Restaurant was among the 2016 Top 25 Restaurants In NJ sponsored by NJ Monthly Magazine, coming out on top of 100’s of other competitors.

Princeton, United States – August 30, 2016 /PressCable/ —

Elements restaurant in Princeton NJ was named one of the Top 25 Restaurants In NJ beating out 100’s of other competitors to take home top honors. NJ Monthly Magazine presented the award to Elements Online. Details about the award can be found on the company website at https://njmonthly.com/articles/eat-drink/best-restaurants-2016/.

Potential award recipients were required to be Nominated by the magazine in order to be in contention for the Top 25 Restaurants In NJ, and were judged based on Food Quality, Customer Service, and Cleanliness. Stephen Distler, Owner of Elements was pleased about the company’s performance, saying:

“Chef Scott Anderson’s inventive and progressive approach to cooking has earned the attention and accolades from some of the industry’s most authoritative voices, including The James Beard Foundation. Chef Anderson is a four years running James Beard semi-finalist for Best Chef in the Mid-Atlantic region and has been acclaimed a vanguard of modern Global-American cuisine. Since first opening in Autumn 2008, elements has garnered the attention of national and regional media, receiving critical acclaim and stellar reviews from The New York Times, Esquire, New Jersey Monthly, Wine Spectator and Opinionated About Dining, among others. Opinioned About Dining recently named elements #27 on the 2016 list of the Top 100 Restaurants in the U.S. Elements is also annual awarded in NJ Monthly’s Best Restaurants List, including the most recent 2016 round-up.”

In developing an ever-changing menu, the team draws inspiration from the earth, championing what grows nearby. Their mornings are spent picking herbs and foraging for the ingredients that are seen in the evening’s dishes. The menu changes daily to reflect the freshest ingredients the Princeton-area has to offer that day.

On weeknights, guests can choose from a four-course prix-fixe menu (also available a la carte), a chef’s tasting (ranging from 10-12 courses) as well as a grand tasting(ranging from 17-22 courses; available with one-week prior notice). On weekends, a five-course tasting, the chef’s tasting or grand tasting menus are exclusively offered.

Each course – presented on earthenware plates and bowls commissioned by local artisans and potters – is delivered tableside by a member of the kitchen team, accompanied by a brief explanation of the dish’s components.

Persons interested in learning more about Elements and the award can visit the website at https://njmonthly.com/articles/eat-drink/best-restaurants-2016/.

For more information, please visit http://www.elementsprinceton.com/

Contact Info:
Name: Stephen Distler
Email: info@elementsprinceton.com
Organization: Elements
Address: 66 Witherspoon St, Princeton, NJ 08542
Phone: (609) 924-0078

Release ID: 130170

GB Minerals Ltd. Announces Rights Offering

VANCOUVER, BC / ACCESSWIRE / August 30, 2016 / GB Minerals Ltd. (TSXV: GBL) (the “Company”) is pleased to announce that is has filed a rights offering notice and a rights offering circular in respect of a rights offering (the “Rights Offering”), pursuant to which each eligible shareholder of the Company (“Shareholder”) will receive, for each common share held as at 5:00 p.m. (Toronto time) on September 8, 2016 (the “Record Date”), one right (each, a “Right”) to subscribe for a common share of the Company (each, a “Common Share”) at a subscription price of C$0.055 per Common Share (the “Subscription Price”).

Details of the Rights Offering

Under the Rights Offering, eligible Shareholders of record as at 5:00 p.m. (Toronto time) on the Record Date will receive one Right for each Common Share held. Each Right entitles the holder thereof to subscribe for one Common Share at the Subscription Price, which represents a discount to the closing price of the Common Shares on August 29, 2016 on the TSX Venture Exchange (the “TSX-V”).

The Rights will be transferable, but will not be listed on the TSX-V or any other exchange. Holders of Rights who wish to exercise or transfer their Rights must do so in the manner described in the rights offering circular dated August 30, 2016 (the “Rights Offering Circular”).

The Rights Offering does not include an “additional subscription privilege” (as such term is defined in National Instrument 45-106 – Prospectus Exemptions of the Canadian Securities Administrators).

The completion of the Rights Offering is not conditional upon any minimum subscription amount. The Company intends to use the funds available from the Rights Offering for the purposes set out in the Rights Offering Circular. Zaff LP (“Zaff”), a significant shareholder of the Company, which competed a US$11.2 million investment in the Company at the Subscription Price in July 2016, has previously agreed that it will not exercise its Rights during the Rights Offering. If all the Rights other than those granted to Zaff are exercised, the Company will receive gross proceeds of approximately C$19.5 million.

The Rights will expire at 5:00 (Toronto time) on October 4, 2016 (the “Expiry Time”). Rights not exercised prior to the Expiry Time will have no value. If a Shareholder does not exercise its Rights and the Rights Offering is completed, such Shareholder’s percentage interest in the Company will be diluted upon the exercise of Rights by other holders of Rights.

The rights offering notice and the Rights Offering Circular setting out important details of the Rights Offering will be filed on SEDAR and available under the Company’s SEDAR profile at www.sedar.com.

Use of Proceeds

The Company has set out its expected use of the proceeds of the Rights Offering in the Rights Offering Circular, and the Company intends to spend the funds as disclosed in the Rights Offering Circular. The Company will reallocate funds only for sound business reasons.

Participation of Insiders

A.B. Aterra Investments Limited and A.B. Aterra Resources Ltd. (together, the “Aterra Entities”), existing significant shareholders of the Company and insiders of the Company, have indicated that they intend to exercise their Rights to acquire additional Common Shares.

Owen Ryan, the chairman and a director of the Company, Luis da Silva, the president and chief executive officer and a director of the Company, and Angel Law, the chief financial officer of the Company, have also indicated that they intend to exercise their Rights to acquire additional Common Shares.

Zaff, an existing significant shareholder of the Company and an insider of the Company, has agreed that it will not exercise its Rights and has indicated that it may or may not transfer to the Aterra Entities the Rights issued to it.

No Offering in the United States

The Rights have not been, and will not be, registered under the United States Securities Act of 1933 (the “U.S. Securities Act”), as amended and may not be offered, sold or delivered, directly or indirectly, in the United States, or to or for the account or benefit to, “U.S. Persons” (as defined under Regulation S under the U.S. Securities Act), except pursuant to an exemption from the registration requirements of the U.S. Securities Act.

ABOUT GB MINERALS LTD.

On September 14, 2015, the Company announced the results of, and filing on SEDAR, of a new feasibility study on its Farim phosphate project entitled “NI 43-101 Technical Report On the Farim Phosphate Project” (the “2015 Feasibility Study”).

The Farim phosphate project is located in the northern part of central Guinea-Bissau, West Africa, approximately 25 kilometres south of the Senegal border, approximately 5 kilometres west of the town of Farim and some 120 kilometres northeast of Bissau, the capital of Guinea-Bissau, on a 30.6 km2 mining lease license granted by the Government of Guinea-Bissau to the Company’s wholly owned subsidiary, GB Minerals AG, in May 2009. The Company also holds a production license in relation to the Farim phosphate project.

The Farim phosphate project consists of a high grade sedimentary phosphate deposit of one continuous phosphate bed which extends over a known surface area of approximately 40 km2. It is estimated to contain measured and indicated resources of 105.6 million dry tonnes at a grade of 28.4% P2O5 and additional inferred resources of 37.6 million dry tonnes at 27.7% P2O5. The measured and indicated resources include 44.0 million dry tonnes of reserves based on a 25 year mine plan at 1.75 million tonnes per annum (“mtpa”) of mine production at the following run of mine grades: 30.0% P2O5, 2.6% Al2O3, 41.0% CaO, 4.7% Fe2O3, and 10.6% SiO2. The phosphate ore will be beneficiated for a final phosphate rock concentrate production of 1.32 mtpa at a 34.0% P2O5 grade at 3% moisture.

The 25 year mine plan also assumes a beneficiation process that involves scrubbing (both drum and attrition) followed by particle sizing to remove the fraction under 20 µm. This new beneficiation process will result in a 34.0% P2O5 product grade, mass recovery of 75.5% and 78.4% P2O5 recovery confirmed by a pilot scale test on a one tonne sample that took place in May 2015. After passing through the process plant, the final production of phosphate concentrate, based on 1.75 mtpa of run of mine feed, will be 1.32 mtpa. The life of mine operating costs are approximately US$52.13 per tonne of final concentrate. The initial capital cost for the project is estimated at US$193.8 million and does not include owner’s costs which amount to US$11 million and include items such as project insurance, resettlement and owner’s team costs. Owner’s costs have been included in the financial analysis.

For additional information, please visit us at www.gbminerals.com.

QUALIFIED PERSON

The Company’s Qualified Person is Dan Markovic, P. Eng., Project/Study Manager at Lycopodium Minerals Canada Ltd., who has reviewed and approves this press release. Mr. Markovic is independent from the Company.

FORWARD LOOKING STATEMENTS

Certain information in this news release relating to the Company is forward-looking and related to anticipated events and strategies. When used in this context, words such as “will”, “anticipate”, “believe”, “plan”, “intend”, “target” and “expect” or similar words suggest future outcomes. Forward-looking information contained in this press release includes, but may not be limited to the anticipated proceeds of the Rights Offering, the use of such proceeds, the business plans, statements or information relating to the anticipated development activities of the Company, the Farim Project (including the quantity and quality of mineral resource and mineral reserve estimates), the potential to upgrade inferred mineral resources, the ability of the Company to develop the Farim Project into a commercially viable mine and the proposed new plans relating thereto regarding operations and mine design, estimates relating to tonnage, grades, recovery rates, future phosphate production, future cash flows, life of mine estimates, expectations regarding production and estimates of capital and operating costs. By their nature, such statements are subject to significant risks and uncertainties that may cause actual results or events to differ materially from current expectations. Readers are cautioned not to place undue reliance on forward-looking information as actual results could differ materially from the plans, expectations, estimates or intentions expressed in the forward-looking information. Forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable law, the Company disclaims any obligation to update or modify such forward-looking information, either as a result of new information, future events or for any other reason.

Disclosure herein of exploration information and of mineral resources and mineral reserves is derived from the 2015 Feasibility Study. Information relating to “mineral resources” and “mineral reserves” is deemed to be forward-looking information as it involves the implied assessment based on certain estimates and assumptions that the mineral resources and mineral reserves can be profitable in the future. Such estimates are expressions of judgment based on knowledge, mining experience, analysis of drilling results and industry practices. Valid estimates made at a given time may significantly change when new information becomes available. By their nature, mineral resource and mineral reserve estimates are imprecise and depend, to a certain extent, upon statistical inferences which may ultimately prove unreliable. If such estimates are inaccurate or are reduced in the future, this could have a material adverse impact on the Company. Accordingly, readers should not place undue reliance on forward-looking information. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Due to the uncertainty that may be attached to inferred mineral resources, it cannot be assumed that all or any part of an inferred mineral resource will be upgraded to an indicated or measured mineral resource as a result of continued exploration.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

SOURCE: GB Minerals Ltd.

ReleaseID: 444541

IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm

IRVINE, CA / ACCESSWIRE / August 30, 2016 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit has been filed against Keryx Biopharmaceuticals Inc. (“Keryx” or the “Company”) (NASDAQ: KERX). Investors who purchased or otherwise acquired shares between February 25, 2016 and August 1, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the October 3, 2016 lead plaintiff motion deadline.

If you purchased Keryx shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, the Company made false and misleading statements and/or failed to disclose: that Keryx was experiencing production-related difficulties in converting API to finished drug product; that the issue was resulting in fewer production yields of finished drug product; that the Company exhausted its reserve of finished drug product; and as a result of the above, Keryx’s statements about its business, operations and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. When this information was disclosed to the public, shares of Keryx dropped in value, causing investors damage.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 444540